GANX
Gain Therapeutics Inc
1.80$
-3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +100.4% | -30.1% | +471.3% | -15.1% | -60.6% | -100.0% | – | |
| – | – | – | +217.1% | +15.1% | -99.0% | +4.6% | +11.9% | |
| – | +100.4% | -30.1% | +471.3% | -15.1% | -60.6% | -252.4% | – | |
| – | +91.8% | +42.4% | +217.1% | +16.9% | +37.5% | -6.3% | -5.4% | |
| – | +150.0% | +125.0% | +446.5% | +39.7% | +13.1% | -11.4% | -11.1% | |
| – | +104.2% | +63.8% | +298.8% | +28.1% | +24.5% | -8.8% | -8.1% | |
| – | – | – | – | – | – | – | – | |
| – | -60.9% | +821.8% | -37.7% | +109.9% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -27.3% | -24.3% | -25.6% | +2,219.8% | -14.7% | +577.2% | +60.4% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.